Hematology

Older adults diagnosed with hematologic malignant neoplasms experience cognitive decline at a rate similar to normal aging.

The ASC4FIRST trial highlights asciminib, a new BCR::ABL1 inhibitor, as a potential alternative to current tyrosine kinase inhibitors for chronic myeloid leukaemia

New research examining nearly three decades of data reveals a concerning rise in stroke rates among both children and adults with sickle cell disease

Children with specific genetic subtypes of acute lymphoblastic leukaemia can achieve excellent outcomes with low-intensity therapy, reducing the risk of severe side effects

A study has revealed important insights into the clonal evolution of blastic plasmacytoid dendritic cell neoplasm, a rare and aggressive blood cancer.

A new study has highlighted the significant risk of iron deficiency among pregnant women, even in high-resource settings

Despite established guidelines, new research has shown that the rate of ischemic stroke in children with sickle cell disease in California has risen.

A recent study has found that haemorrhages are far more frequent in cancer patients than previously believed, posing a serious threat to their prognosis and overall survival